MedPath

The efficacy of autologous Platelet-Rich Plasma (PRP) for the adjuvant treatment of Frontal Fibrosing Alopecia (FFA), a randomized, controlled trial, split-scalp study

Phase 1
Conditions
Frontal Fibrosing Alopecia
FFA
Registration Number
TCTR20231021001
Lead Sponsor
Ratchadapiseksompotch Research Fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
30
Inclusion Criteria

1. The subject is aged > 18 years 2. FFA patient who has active disease 3. Subjects who can comply with trial procedures and are available for the duration of follow-up

Exclusion Criteria

1. pregnancy of breast feeding patient
2. Subjects who has abnormal coagulation
3. Subjects who can not comply with trial procedures and are available for the duration of follow-up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sign of inflammation 9 months grading sign of inflammation
Secondary Outcome Measures
NameTimeMethod
hair density 9 months hair count/cm2,hairline recession 9 months centimeter,patient satisfaction 9 months score
© Copyright 2025. All Rights Reserved by MedPath